Clinical Trials Directory

Trials / Unknown

UnknownNCT03941470

Assessment of Natural Killer Cells in Unexplained Recurrent Pregnancy Loss

Assessment of Natural Killer Cells Activating and Inhibitors

Status
Unknown
Phase
Study type
Observational
Enrollment
60 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
Female
Age
35 Years
Healthy volunteers
Not accepted

Summary

To assess natural killer cells frequency and activation in cases of unexplained recurrent abortion in comparison to fertile cases * 2\. . To study the expression of stimulatory receptors of natural killer cell. * 3-To study the expression of inhibitory receptors of natural killer cell.

Detailed description

NK-cell functioning is controlled by a wide range of receptors that are expressed on the cell surface. These receptors are either inhibitory or activating in nature. The family of inhibitory receptors consists of the killer immunoglobulin-like receptors (KIR) or Ig-like receptors (CD158), the C type lectin receptors (CD94-NKG2A) and leukocyte inhibitory receptors (LIR1, LAIR-1). Activating receptors are the natural cytotoxic receptors (NKp46, NKp44), C type lectin receptors (NKG2D, CD94-NKG2C), and Ig-like receptors (2B4). A particular NK cell typically expresses two to four inhibitory receptors in addition to an array of activation receptors. The killing by NK cells is mediated through several activating NK receptors. Among these are NKG2D and the three natural cytotoxicity receptors (NCRs), NKp30, NKp44, and NKp46 (Yang et al., 2000) Osne of the natural cytotoxicity receptors (NCRs) NKp46, , is a unique marker that functions in NK cell cytotoxicity and cytokine production. Expression of NKp46 on NK cells is lower in women with recurrent pregnancy loss, so evaluation of NKp46 on peripheral blood NK cells may provide a means of screening for reproductive abnormalities (Fukui et al., 2015). During pregnancy, decidual NK cells comprise ∼70-80% of the decidual lymphocytes and are considered a special NK subset that does not exert cytolytic functions against trophoblast cells and has generally reduced cytotoxicity (Hanna and Mandelboim, 2007). These cells express activating NK receptors, including all the NCRs and NKG2D. However, instead of triggering cytotoxicity, these receptors act to stimulate secretion of cytokines and angiogenic factors, which are essential for trophoblast invasion and vascular modifications (Hanna et al., 2006). One study reported that pNK cell levels show changes in decidual NK cell levels (Park et al., 2010). Whereas some other reports have shown that the assessment of peripheral blood NK cells would not

Conditions

Timeline

Start date
2019-04-30
Primary completion
2019-12-01
Completion
2020-07-20
First posted
2019-05-08
Last updated
2019-05-08

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03941470. Inclusion in this directory is not an endorsement.